Gilead quarterly profit falls as COVID antiviral sales decrease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/28/2026

1. NVDA
2. SPCX
3. META
4. MDB
5. USO
6. MU
7. KOD
8. MIRM
9. LLY
10. SPY

Go back to Gilead quarterly profit falls as COVID antiviral sales decrease
Gilead Sciences (NASDAQ: GILD) Delayed: 152.21 +1.28 (0.85%)
Previous Close $150.93    52 Week High $108.63 
Open $149.79    52 Week Low $71.39 
Day High $152.74    P/E 84.09 
Day Low $149.41    EPS $1.81 
Volume 5,081,831